Tabuso, Bernie A.

HRN: 03-29-94  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/11/2026
METRONIDAZOLE 500MG (TAB)
02/11/2026
02/16/2026
ORAL
500mg
Q8
Acute Gangrenous Appendicitis
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines